Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03368989 · ClinicalTrials.gov registry record
The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 21
- Enrollment target
NCT03368989 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 21 participants.
The verdict
NCT03368989 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
To describe the changes seen on bone scan and correlate them with changes in relative chemical biomarkers, patient's functional status and level of pain.
Interventions
- DRUG Radium-223 dichloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-02-11 |
| Est. Completion | 2017-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03368989
The ClinicalTrials.gov registry entry for NCT03368989 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radium-223 dichloride is the first listed.
NCT03368989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03368989 about?
NCT03368989 is a clinical study titled "The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.". To describe the changes seen on bone scan and correlate them with changes in relative chemical biomarkers, patient's functional status and level of pain.
What is the current status of trial NCT03368989?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-02-11. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT03368989?
The interventions under investigation include: Radium-223 dichloride (DRUG).
Who is sponsoring clinical trial NCT03368989?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.